Guardant Health
GH
#1029
Rank
โ‚น2.188 T
Marketcap
โ‚น16,305
Share price
-3.90%
Change (1 day)
85.79%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -โ‚น41.75 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น1.18 Billion. In 2025 the company made an earning of -โ‚น39.63 Billion, an increase over its 2024 earnings that were of -โ‚น41.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น41.75 Billion5.36%
2025 -โ‚น39.63 Billion-4.03%
2024 -โ‚น41.29 Billion-9.12%
2023 -โ‚น45.43 Billion-26.73%
2022 -โ‚น62.01 Billion69.96%
2021 -โ‚น36.49 Billion56.35%
2020 -โ‚น23.34 Billion252.69%
2019 -โ‚น6.62 Billion-17.22%
2018 -โ‚น8 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚น0.85 Billion-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น23.98 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA